Literature DB >> 27038727

Medication adherence to rivaroxaban and dabigatran for stroke prevention in patients with non-valvular atrial fibrillation in the United States.

Craig I Coleman1, Muralikrishna Tangirala2, Thomas Evers3.   

Abstract

Entities:  

Keywords:  Dabigatran; Medication adherence; Non-valvular atrial fibrillation; Proportion of days covered; Rivaroxaban

Mesh：

Substances：

Year:  2016        PMID： 27038727     DOI： 10.1016/j.ijcard.2016.03.051

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN： 0167-5273            Impact factor:   4.164


× No keyword cloud information.
  9 in total

1.  Medication adherence to rivaroxaban and dabigatran in patients with non-valvular atrial fibrillation: a meta-analysis.

Authors:  Ashley Prentice; Irene Ruiz; Erin R Weeda
Journal:  J Thromb Thrombolysis       Date:  2020-04       Impact factor: 2.300

2.  Anti-FXa-IIa activity test in Asian and its potential role for drug adherence evaluation in patients with direct oral anticoagulants: a nationwide multi-center synchronization study.

Authors:  Zhiyan Liu; Qiufen Xie; Qian Xiang; Hanxu Zhang; Guangyan Mu; Zinan Zhao; Taotao Hu; Tingting Wu; Na Wang; Jinhua Zhang; Yan Qian; Shuang Zhou; Zining Wang; Jie Jiang; Yatong Zhang; Hongtao Song; Yimin Cui
Journal:  Cardiovasc Diagn Ther       Date:  2020-10

3.  Association between medication adherence and illness perceptions in atrial fibrillation patients treated with direct oral anticoagulants: An observational cross-sectional pilot study.

Authors:  Motoyasu Miyazaki; Akio Nakashima; Yoshihiko Nakamura; Yuya Sakamoto; Koichi Matsuo; Miwa Goto; Masanobu Uchiyama; Keisuke Okamura; Ryoko Mitsutake; Hidenori Urata; Hidetoshi Kamimura; Osamu Imakyure
Journal:  PLoS One       Date:  2018-09-28       Impact factor: 3.240

4.  The daily practice of direct oral anticoagulant use in patients with atrial fibrillation; an observational cohort study.

Authors:  Anouk J W Gulpen; Hugo Ten Cate; Yvonne M C Henskens; René van Oerle; Rick Wetzels; Simon Schalla; Harry J Crijns; Arina J Ten Cate-Hoek
Journal:  PLoS One       Date:  2019-06-06       Impact factor: 3.240

5.  Real-world adherence to oral anticoagulants in atrial fibrillation patients: a study protocol for a systematic review and meta-analysis.

Authors:  Clara L Rodríguez-Bernal; Aníbal García-Sempere; Isabel Hurtado; Yared Santa-Ana; Salvador Peiró; Gabriel Sanfélix-Gimeno
Journal:  BMJ Open       Date:  2018-12-19       Impact factor: 2.692

6.  Adherence to oral anticoagulants among patients with atrial fibrillation: a systematic review and meta-analysis of observational studies.

Authors:  Shahrzad Salmasi; Peter S Loewen; Rachel Tandun; Jason G Andrade; Mary A De Vera
Journal:  BMJ Open       Date:  2020-04-08       Impact factor: 2.692

7.  Assessing Adherence and Persistence to Non-vitamin K Antagonist Oral Anticoagulants (NOACs) among Patients with Atrial Fibrillation in Tertiary-care Referral Centers in Malaysia.

Authors:  Mohammed A Kubas; Fatiha Hana Shabaruddin; Wardati Mazlan-Kepli; Nirmala Jagan; Sahimi Mohamed; Nor Ilyani Mohamed Nazar; Che Suraya Zin
Journal:  J Pharm Bioallied Sci       Date:  2020-11-05

8.  Adherence to rivaroxaban for the treatment of venous thromboembolism-Results from the FIRST registry.

Authors:  Victoria Speed; Vivian Auyeung; Jignesh P Patel; Derek Cooper; Stephen Miller; Lara N Roberts; Raj K Patel; Roopen Arya
Journal:  Res Pract Thromb Haemost       Date:  2021-11-21

9.  Indications for suboptimal low-dose direct oral anticoagulants for non-valvular atrial fibrillation patients.

Authors:  Masahiko Umei; Mikio Kishi; Takahiro Sato; Akito Shindo; Masayuki Toyoda; Masaaki Yokoyama; Masashiro Matsushita; Satoshi Ohnishi; Masao Yamasaki
Journal:  J Arrhythm       Date:  2017-06-30
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.